← All Authorities
Singapore patent linkageregulatory

Millennium Pharmaceuticals Inc v Drug Houses of Australia Pte Ltd

[2019] SGCA 31; [2019] 2 SLR 1017
JurisdictionSingapore
CourtSingapore Court of Appeal
Year2019
StatusBinding authority

Key Principle

The Court of Appeal held that, under Singapore's patent-linkage regime, a process (manufacturing) patent can be a 'patent in respect of the therapeutic product' that a generic applicant must declare to the Health Sciences Authority, so the term 'patent' is not confined to product patents.

Area of Law

ip

Related Cases

Element Six Technologies Ltd v IIa Technologies Pte Ltd [2020] SGHC 26
Ceramiche Caesar SpA v Caesarstone Sdot-Yam Ltd Ceramiche Caesar SpA v Caesarstone Sdot-Yam Ltd [2017] SGCA 30, [2017] 2 SLR 308
Global Yellow Pages Ltd v Promedia Directories Pte Ltd [2017] 2 SLR 185

Ask CommonBench about this case

Get a detailed analysis of Millennium Pharmaceuticals Inc v Drug Houses of Australia Pte Ltd and how it applies to your situation.

Explain Millennium Pharmaceuticals Inc...